Literature DB >> 10589431

Transient transfection of Schneider cells in the study of transcription factors.

G Suske1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10589431     DOI： 10.1385/1-59259-686-x:175

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  9 in total

1.  Transcription factor Sp3 is regulated by acetylation.

Authors:  H Braun; R Koop; A Ertmer; S Nacht; G Suske
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.

Authors:  George Koutsodontis; Eleftheria Vasilaki; Wan-Chih Chou; Paraskevi Papakosta; Dimitris Kardassis
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

4.  Sequential repression and activation of the CCAAT enhancer-binding protein-alpha (C/EBPalpha ) gene during adipogenesis.

Authors:  M S Jiang; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

Authors:  David M Cauvi; Gabrielle Cauvi; K Michael Pollard
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

6.  Transcriptional regulation of pro-apoptotic protein kinase Cdelta: implications for oxidative stress-induced neuronal cell death.

Authors:  Huajun Jin; Arthi Kanthasamy; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

7.  Transcription factor Sp3 is silenced through SUMO modification by PIAS1.

Authors:  Alexandra Sapetschnig; Grigore Rischitor; Harald Braun; Andreas Doll; Marion Schergaut; Frauke Melchior; Guntram Suske
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

8.  Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.

Authors:  Bérengère Vire; Stéphane de Walque; Audrey Restouin; Daniel Olive; Carine Van Lint; Yves Collette
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

9.  Human NCU-G1 can function as a transcription factor and as a nuclear receptor co-activator.

Authors:  Knut R Steffensen; Mariam Bouzga; Frode Skjeldal; Cecilie Kasi; Almira Karahasan; Vilborg Matre; Oddmund Bakke; Sylvain Guérin; Winnie Eskild
Journal:  BMC Mol Biol       Date:  2007-11-16       Impact factor: 2.946
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.